Answers are grounded in this paper and cite their sources.
Molecularly targeted near-infrared fluorescence imaging offers a promising approach to delineating cutaneous squamous cell carcinoma while preserving healthy tissue. This narrative review integrates target biology, probe chemistry, experimental performance, and translational development, with particular attention to epidermal growth factor receptor, integrins, vascular endothelial growth factor, interleukin-6 receptor, and emerging molecular and organelle targets. Antibody conjugates have visualized cutaneous squamous cell carcinoma xenografts and patient-derived tumor grafts, while activatable probes and ex vivo human-specimen imaging provide a bridge to pathology-linked assessment. Studies in oral and other cancers contribute transferable strategies for topical delivery, fluorescence lifetime imaging, dual recognition, and microenvironment-responsive activation. Comparative assessment connects each probe class with its recognition mechanism, acquisition conditions, and reported biological or imaging end points. Photothermal, photodynamic, and photoimmunotherapy systems illustrate how imaging can be integrated with localized treatment and response monitoring. The review also identifies practical priorities for translation, including target accessibility, pharmacokinetics, construct-specific safety, calibrated acquisition, and prospective pathology-registered evaluation. These advances support the development of fluorescence-assisted localization and specimen assessment as complementary tools within established skin-cancer care.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: